baicalin has been researched along with Alcoholic Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chen, Z; Ke, X; Li, P; Luo, X; Wang, J; Wang, M; Zhang, R; Zuo, L | 1 |
| Kim, SJ; Lee, SM | 1 |
2 other study(ies) available for baicalin and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Baicalin ameliorates alcohol-induced hepatic steatosis by suppressing SREBP1c elicited PNPLA3 competitive binding to ATGL.
Topics: Animals; Binding, Competitive; Ethanol; Fatty Liver, Alcoholic; Flavonoids; Liver; Rats; Sterol Regulatory Element Binding Protein 1 | 2022 |
Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Fatty Liver, Alcoholic; Flavonoids; Interleukin-6; Liver; Male; Myeloid Differentiation Factor 88; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Toll-Like Receptor 4; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |